Yukin Therapeutics is a French biotechnology company. The company focuses on the development of new therapeutic molecules, entitled kinase inhibitors, specifically targeting a protein involved in the development of several types of cancer: the NIK protein (NF-κB inducing kinase). Yukin Therapeutics led studies that demonstrated proof of concept inanimal models and is now actively seeking to identify a first drug candidate to launch a clinical trial in oncology.

Biotechnology

Pharmaceutical

YUKIN THERAPEUTICS

YUKIN THERAPEUTICS' headquarters in Biot, France

Description

People (2)

Arnaud Foussat

Pascal Dao

Jobs